Loading...
Mismatch Repair Deficiency as a Predictive Biomarker for Immunotherapy Efficacy
Immunotherapy has revolutionized cancer treatment. Immune-checkpoint inhibitors, on balance, showed a favorable efficacy/toxicity profile with durable response in different cancer types. No predictive biomarker has been validated thus far to select patients who would benefit from therapy. Among the...
Na minha lista:
| Udgivet i: | Biomed Res Int |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Hindawi
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5523547/ https://ncbi.nlm.nih.gov/pubmed/28770222 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/4719194 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|